Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ChampionX Corp C.CHX


Primary Symbol: CHX

ChampionX Corporation is engaged in offering chemistry solutions, artificial lift systems, and engineered equipment and technologies that help companies drill for and produce oil and gas. The Company’s Production Chemical Technologies segment offers products and services that cover a range of onshore, offshore, and oil sands chemical solutions in production and midstream operations. Its Production & Automation Technologies segment offers products, technologies, and services that facilitate the extraction of oil and gas through artificial lift and digital automation applications. It designs, manufactures, markets a full range of artificial lift equipment, end-to-end automation, and digital solutions, and other production equipment and emissions monitoring solutions. Its Drilling Technologies segment offers polycrystalline diamond cutter (PDC) inserts, bearings, valves, and mining tools. Its Reservoir Chemical Technologies segment offers chemistry-oriented solutions and technologies.


NDAQ:CHX - Post by User

Post by hockeytownon Jul 31, 2017 8:49pm
123 Views
Post# 26531390

News

News

2017-07-31 16:21 ET - News Release

 

Mr. Ash Kaushal reports

CHROMEDX WORKS TOWARDS THIRD VERSION OF HEMOPALM PROTOTYPE ANALYZER

ChroMedX Corp. has provided an update on the refinement and testing of the company's HemoPalm system prototype.

The company completed its first HemoPalm system prototype in mid-May in collaboration with rapid prototyping firm Agile Manufacturing Inc. ChroMedX has continued to refine the design and is now in the process of finalizing a third version that addresses key aspects of the size, durability and ergonomics of the device.

"This is a very involved and fast-paced part of the development process. Our third reiteration includes considerable refinements to the usability of the device. Not only will the size of the device decrease, but we will increase durability by optimizing the internal layout of the device's components -- a process made much easier by the accessibility of rapid prototyping," said Ash Kaushal, president and chief executive officer, ChroMedX.

Prototype refinement is overseen by Mr. Kaushal. Rapid prototyping is managed in collaboration with Agile Manufacturing of Uxbridge, Ont., Canada, and continuing refinement of components is managed internally and at the company's Shenzhen-based development partner Hochuen Technologies Co.

U.S. trading

ChroMedX is pleased to announced that earlier this month, the company commenced trading on the OTCQB under the symbol CHXIF. Complete trading details can be found on the OTC markets website.

Website

The company is also pleased to announced the launch of a new website. Investors and individuals interested in keeping abreast of the latest news and updates can subscribe on the home and news pages on the company's website or communicate on the website's contact page.

About ChroMedX Corp.

ChroMedX is a medical technology company focused on the development of novel medical devices for in vitro diagnostics and point-of-care testing.

The HemoPalm hand-held blood analyzer system is the only hand-held blood analysis technology, which combines blood gases and electrolytes with full co-oximetry. Currently, this combination is not available on any of the hand-held analyzers on the market. Another competitive advantage of the HemoPalm system will be its ability to draw capillary blood directly from a pinprick site into the cartridge, providing an alternative to arterial blood.

We seek Safe Harbor.

 
<< Previous
Bullboard Posts
Next >>